Table 3

 Comparison of data between patients with complete reversal of Barrett’s oesophagus and patients with residual intestinal metaplasia (IM) post ablation

Complete reversal (n = 24)Residual IM (n = 11)p Value
BO, Barrett’s oesophagus; PPI, proton pump inhibitor; APC, argon plasma coagulation; MPEC, multipolar electrocoagulation.
Age (y) (median (range))61.5 (32–78)66 (42–84)0.13
No of treatments (median (range))3 (2–6)5 (2–6)0.32
BO length (cm) (median (range))3.5 (2–6)3 (2–6)0.85
24 hour pH monitoring
    Total time pH <4 (%) (median (range))0.5 (0–29.9)0.7 (0–28.2)1.0
    Supine time pH <4 (%) (median (range))0 (0–47.2)0 (0–39.6)0.54
    Upright time pH <4 (%) (median (range))0.6 (0–47.9)1.1 (0–22.1)0.76
No of patients with normal total pH study (%)18 (75)8 (72.7)1.00
    Abnormal6 (25)3 (27.3)
No of patients with normal supine pH study (%)20 (83.3)7 (63.6)0.22
    Abnormal4 (16.7)4 (36.4)
No of patients with normal upright pH study (%)18 (75)10 (90.9)0.39
    Abnormal6 (25.0)1 (9.1)
Hiatal hernia size (cm) (median (range))3 (0–6)3 (1–5)0.22
Maintenance PPI dose (median (range))30 (20–60)20 (20–80)0.57
Ablation therapy
    APC12 (50.0)7 (63.6)0.49
    MPEC12 (50.0)4 (36.4)